Daniel de Boer
Chief Executive Officer chez PROQR THERAPEUTICS N.V.
Fortune : 2 M $ au 31/03/2024
Profil
Daniel Anton de Boer is the founder of ProQR Therapeutics NV, PC Basic B.V., and Running It.
He held the position of Chief Executive Officer at each of these companies.
Additionally, he is also the founder of Amylon Therapeutics BV.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROQR THERAPEUTICS N.V.
0,87% | 31/12/2023 | 705 309 ( 0,87% ) | 2 M $ | 31/03/2024 |
Postes actifs de Daniel de Boer
| Sociétés | Poste | Début |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Chief Executive Officer | 21/02/2012 |
Anciens postes connus de Daniel de Boer
| Sociétés | Poste | Fin |
|---|---|---|
| Running It | Chief Executive Officer | 01/09/2011 |
| PC Basic B.V. | Chief Executive Officer | 01/02/2008 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Founder | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| PC Basic B.V. | |
| Running It | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
